Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
CoreMap, a US-based developer of a cure for atrial fibrillation spun out of University of Vermont, has concurrently completed a $3m series A extension and $20m series B round from undisclosed strategic, institutional, venture and individual investors. CoreMap previously raised an initial $10.5m in series A financing led by Qure Ventures, with participation from The Fund at Hula, in September 2020.
Odaia, a Canada-based commercial insights platform aimed at pharmaceutical firms based on University of Toronto research, has obtained $13.8m…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
